By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BioMarker Strategies said today that it has won a Phase II contract valued at up to $2.3 million from the National Cancer Institute to develop its live tumor cell testing system.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.
With a new collection, PLOS highlights negative results it has published.
A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.
The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.